D. E. Shaw & Co., Inc. Intercept Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $1.23 Million - $2.31 Million	123,356 Added 18.47%	791,335 $14.7 Million
Q2 2023 Aug 14, 2023	BUY	$9.17 - $19.29 $898,238 - $1.89 Million	97,954 Added 17.18%	667,979 $7.39 Million
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $4.55 Million - $7.88 Million	362,943 Added 175.27%	570,025 $7.66 Million
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $2.06 Million - $2.86 Million	177,740 Added 605.75%	207,082 $2.56 Million
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $358,265 - $578,037	29,342 New	29,342 $409,000

Q1 2022 May 16, 2022	SELL	$13.37 - $17.79 $635,529 - $845,629	-47,534 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $156,837 - $214,497	10,983 Added 30.05%	47,534 $774,000
Q3 2021 Nov 15, 2021	BUY	$12.99 - $20.47 $280,025 - $441,271	21,557 Added 143.77%	36,551 $543,000
Q1 2021 May 17, 2021	BUY	$19.33 - $37.75 $483 - $943	25 Added 0.17%	14,994 $346,000
Q4 2020 Feb 16, 2021	SELL	$24.48 - $42.47 $1.13 Million - $1.97 Million	-46,318 Reduced 75.58%	14,969 $370,000
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $961,105 - $1.31 Million	24,587 Added 66.99%	61,287 $2.54 Million
Q2 2020 Aug 14, 2020	SELL	$46.7 - $92.04 $2.62 Million - $5.16 Million	-56,035 Reduced 60.42%	36,700 $1.76 Million
Q1 2020 May 15, 2020	BUY	$48.35 - $118.68 $1.89 Million - $4.63 Million	39,007 Added 72.6%	92,735 $5.84 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $2.92 Million - $6.32 Million	50,928 Added 1818.86%	53,728 $6.66 Million
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $1.52 Million - $2.35 Million	-19,503 Reduced 87.45%	2,800 $223,000
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $17.5 Million - $23.1 Million	-191,037 Reduced 89.55%	22,303 $2.5 Million
Q4 2018 Feb 14, 2019	BUY	$85.79 - $126.46 $745,086 - $1.1 Million	8,685 Added 4.24%	213,340 $21.5 Million
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $15.2 Million - $21.8 Million	171,303 Added 513.62%	204,655 $25.9 Million
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $667,200 - $952,650	11,120 Added 50.02%	33,352 $2.8 Million
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $1.91 Million - $2.39 Million	-32,800 Reduced 59.6%	22,232 $1.3 Million
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $3.14 Million - $6.54 Million	55,032	55,032 $3.19 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account